Drug Trial Radar · NCT07655804
Subcutaneous Calcitonin in Acute Herpes Zoster
Last checked: Nov 20, 2026Latest source record: Jul 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
168
Planned (sponsor's estimate)
Start
Jul 1, 2026
Primary completion
Apr 1, 2027
Study completion Oct 1, 2027
Sponsor
- Lead sponsor
- Tanta UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Jun 18, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated drug
- No
- Who can join
- All sexes, from 50 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This prospective randomized controlled study will be conducted to evaluate the effect of adding calcitonin to the standard treatment protocol in patients with acute herpes zoster infection.
Conditions
- Calcitonin
- Subcutaneous
- Acute Herpes Zoster
Interventions
CalcitoninDrug
patients will receive subcutaneous salmon calcitonin 100 IU (ampoule = 1 ml) daily for three weeks
SalineOther
patients will receive subcutaneous saline (1 ml) daily for three weeks.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of postherpetic neuralgia at 3 months after rash onset.Time frame: 3 months after onset of acute herpes zoster rash.
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Tanta University Hospitals
Tanta, Gharbia Governorate, Egypt · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.